Marcel A van Schie1, Cuong V Dinh1, Petra J van Houdt1, Floris J Pos1, Stijn W T J P Heijmink2, Linda G W Kerkmeijer3, Alexis N T J Kotte3, Raymond Oyen4, Karin Haustermans5, Uulke A van der Heide6. 1. Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. 2. Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. 3. Department of Radiation Oncology, University Medical Center, Utrecht, The Netherlands. 4. Department of Radiology, University Hospitals, Leuven, Belgium. 5. Department of Radiation Oncology, University Hospitals, Leuven, Belgium. 6. Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: u.vd.heide@nki.nl.
Abstract
PURPOSE: To date no guidelines are available for contouring prostate cancer inside the gland, as visible on multiparametric (mp-) MRI. We assessed inter-institutional differences in interpretation of mp-MRI in the multicenter phase III FLAME trial. METHODS: We analyzed clinical delineations on mp-MRI and clinical characteristics from 260 patients across three institutes. We performed a logistic regression analysis to examine each institute's weighting of T2w, ADC and Ktrans intensity maps in the delineation of the cancer. As reviewing of all delineations by an expert panel is not feasible, we made a selection based on discrepancies between a published tumor probability (TP) model and each institute's clinical delineations using Areas Under the ROC Curve (AUC) analysis. RESULTS: Regression coefficients for the three institutes were -0.07, -0.27 and -0.11 for T2w, -1.96, -0.53 and -0.65 for ADC and 0.15, 0.20 and 0.62 for Ktrans, with significant differences between institutes for ADC and Ktrans. AUC analysis showed median AUC values of 0.92, 0.80 and 0.79. Five patients with lowest AUC values were reviewed by a uroradiologist. CONCLUSION: Regression coefficients revealed considerably different interpretations of mp-MRI in tumor contouring between institutes and demonstrated the need for contouring guidelines. Based on AUC values outlying delineations could efficiently be identified for review.
RCT Entities:
PURPOSE: To date no guidelines are available for contouring prostate cancer inside the gland, as visible on multiparametric (mp-) MRI. We assessed inter-institutional differences in interpretation of mp-MRI in the multicenter phase III FLAME trial. METHODS: We analyzed clinical delineations on mp-MRI and clinical characteristics from 260 patients across three institutes. We performed a logistic regression analysis to examine each institute's weighting of T2w, ADC and Ktrans intensity maps in the delineation of the cancer. As reviewing of all delineations by an expert panel is not feasible, we made a selection based on discrepancies between a published tumor probability (TP) model and each institute's clinical delineations using Areas Under the ROC Curve (AUC) analysis. RESULTS: Regression coefficients for the three institutes were -0.07, -0.27 and -0.11 for T2w, -1.96, -0.53 and -0.65 for ADC and 0.15, 0.20 and 0.62 for Ktrans, with significant differences between institutes for ADC and Ktrans. AUC analysis showed median AUC values of 0.92, 0.80 and 0.79. Five patients with lowest AUC values were reviewed by a uroradiologist. CONCLUSION: Regression coefficients revealed considerably different interpretations of mp-MRI in tumor contouring between institutes and demonstrated the need for contouring guidelines. Based on AUC values outlying delineations could efficiently be identified for review.
Authors: Daniel Gorovets; Andreas G Wibmer; Assaf Moore; Stephanie Lobaugh; Zhigang Zhang; Marisa Kollmeier; Sean McBride; Michael J Zelefsky Journal: Eur Urol Oncol Date: 2022-03-17
Authors: Tonghe Wang; Robert H Press; Matt Giles; Ashesh B Jani; Peter Rossi; Yang Lei; Walter J Curran; Pretesh Patel; Tian Liu; Xiaofeng Yang Journal: Br J Radiol Date: 2019-04-09 Impact factor: 3.039
Authors: Michelle D Bardis; Roozbeh Houshyar; Peter D Chang; Alexander Ushinsky; Justin Glavis-Bloom; Chantal Chahine; Thanh-Lan Bui; Mark Rupasinghe; Christopher G Filippi; Daniel S Chow Journal: Cancers (Basel) Date: 2020-05-11 Impact factor: 6.639